Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda

NACompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

November 29, 2019

Study Completion Date

May 30, 2020

Conditions
Respiratory Tract InfectionsDiarrheaSkin DiseasesTinea CapitisCommon Cold
Interventions
DIETARY_SUPPLEMENT

Probiotic

"Probiotics are defined by the Food and Agricultural Organization (FAO)/WHO as live microorganisms, which when consumed in adequate amounts, confer a health benefit on the host. Lactobacillus rhamnosus GG (LGG) is the most documented probiotic bacteria, with many proven unique characteristics and therewith associated health benefits. No adverse effects of the consumption of LGG in healthy infants have been reported. The Lactobacillus rhamnosus yoba containing yoghurt drink, which is locally produced and subsequently consumed by resource-poor communities in rural Uganda has been described. The strain used in this intervention is a generic variant of LGG, called Lactobacillus rhamnosus yoba 2012. LGG is consumed as part of food all over the world, and is not a drug.~100ml of yoghurt containing Lactobacillus rhamnosus yoba 2012 will be consumed 5 days per week, for 9 weeks."

DIETARY_SUPPLEMENT

Placebo

100ml of custard will be consumed 5 days per week, for 9 weeks.

Trial Locations (1)

Unknown

Paragon primary and nursery School, Kabwohe

All Listed Sponsors
collaborator

Yoba for Life Foundation

UNKNOWN

lead

VU University of Amsterdam

OTHER

NCT04144491 - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda | Biotech Hunter | Biotech Hunter